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Social inequalities in quitting smoking: What factors 
mediate the relationship between socioeconomic 
position and smoking cessation? 
 
 
ABSTRACT 
 
 
Background:  Smokers from lower socio-economic groups are less likely to be successful 
in a quit attempt than more affluent smokers, even when they access smoking cessation 
services.   
 
 
Methods: Data were collected from smoking cessation service users from three 
contrasting areas of Great Britain – Glasgow, North Cumbria and Nottingham.  Routine 
monitoring data were supplemented with CO validated smoking status at 52 week follow 
up and survey data on socio-economic circumstances and smoking-related behaviour. 
Analysis was restricted to the 2397 clients aged between 25 and 59. 
 
 
Results: At 52 week follow up 14.3% of the most affluent smokers remained quit 
compared with only 5.3% of the most disadvantaged.  After adjustment for demographic 
factors,  the most advantaged clients at the English sites and the Glasgow one to one 
programme were significantly more likely to have remained abstinent than those who were 
most disadvantaged (OR 2.5, CI 1.4 – 4.7 and 7.5  CI 1.4 to 40.3 respectively).  
Mechanisms producing the inequalities appeared to include treatment compliance, 
household smokers and referral source. 
 
 
Conclusions: Rather than quitting smoking, disadvantaged smokers quit treatment.  More 
should be done to encourage them to persevere through the first few weeks.  Other causes 
of inequalities in quitting varied with the service provided. 
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INTRODUCTION 
 
In England, one in five adults smokes and tobacco causes 18% of deaths (1-2).  In 
Scotland smoking rates are higher, at 24% (2) and smoking is estimated to account for up 
to 27% of deaths (1, 3).  Tobacco is responsible for about half the socioeconomic position 
(SEP) difference (as measured through social class, income or education) in death rates (4) 
because smoking rates are higher among those with lower SEP in the majority of 
developed countries (5).  Although smoking rates have been falling in the developed 
world, reductions have been slower amongst disadvantaged smokers and inequalities in 
smoking rates have increased in recent years (6).   
 
SEP differences in quit rates and low quit rates among disadvantaged smokers have also 
been observed in studies of many smoking cessation interventions (7).  There is some 
evidence to suggest that smoking cessation programmes that provide a combination of 
pharmacotherapy and structured behavioural support together appear to have some success 
among disadvantaged smokers (8-9).  Quit rates in these types of interventions are poorer 
among disadvantaged smokers than for more affluent smokers but this can be mitigated by 
focussing resources on disadvantaged communities (8).  If a greater proportion of 
disadvantaged than affluent smokers are encouraged to take up an intervention then the 
gap in smoking is less likely to widen (8-9).   
 
Why do socioeconomically disadvantaged smokers find quitting more difficult? Possible 
reasons include lack of support for quit attempts, greater addiction to tobacco, less 
motivation to quit and less compliance with treatment. Features of cessation programmes 
may also favour high SEP groups such as referral routes and the structure or timing of 
treatment.  Smokers with low SEP may find quitting more difficult due to less support 
from their family or community for their quit attempt (10).  This may be because there is a 
higher proportion of smokers in their social network and/or their spouse or partner may be 
more likely to smoke (11).  This lack of support has been identified as a reason for low 
quit rates among disadvantaged smokers (12).  Addiction plays a powerful role in 
mediating the outcome of any quit attempt (10).  The majority of smokers are highly 
dependent on tobacco and despite being motivated to quit smoking and being aware of the 
threat to health many regular smokers are unsuccessful in their quit attempts (13-14).  
Disadvantaged smokers are often more highly addicted, for example they may smoke 
more cigarettes a day or smoke on waking, thus they may find quitting harder (6, 15).  
Addiction has been found to explain some of the relationship between SEP and quitting 
(16). 
 
Motivation is an important driver underlying successful smoking cessation (17).  There 
have been inconsistent findings, however, on whether motivation to quit differs by SEP (6, 
18). Likewise, use of pharmacotherapy and smoking cessation services has not been found 
to explain the relationship between SEP and quitting, particularly in the UK.  It may be, 
however, that stronger commitment to effectively using pharmacotherapy and to keep 
attending services is important for quitting (19-20).  Disadvantaged smokers are less likely 
to comply (20-21).  In this paper we use the term compliance to describe engagement with 
and adherence to a smoking cessation programme. We acknowledge that this term is 
contested and has been described as denoting a somewhat paternalistic attitude towards 
non adherers (22-23). However, compliance is a term widely used in the literature on 
smoking cessation and for consistency we use it in this study(e.g. 6). 
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The nature of smoking cessation programmes is also likely to affect the chances of 
quitting.  In a review of 50 RCTs (24) and another review of 23 studies since January 
2000 (25) group-based behavioural support was not found to be significantly different to 
one to one support.  However in a review of the effectiveness of the UK’s NHS stop 
smoking services (26) group support was found to achieve a higher quit rate than one to 
one support, but one to one interventions had a higher uptake.   
 
In 2009 Kotz and West described findings from the English Smoking Toolkit Survey 
which consistently showed a strong socio-economic gradient in the success of quit 
attempts. They concluded that: “there is a strong gradient across socioeconomic groups in 
success… Determining the cause of, and counteracting, this gradient is paramount in 
reducing health inequalities.”(6 p43).  The present study aims to directly address the first 
part of Kotz and West’s conclusion by exploring the pathway between socioeconomic 
position and smoking cessation amongst smokers who tried to quit with the support of 
NHS Stop Smoking Services in the UK. 
 
 
METHODS 
 
This paper reports results from secondary analysis of data collected in two separate studies 
of NHS smoking cessation programmes. The studies employed an identical research 
design and were conducted by the same research team. The smoking cessation 
programmes studied were an intensive group programme and one to one support in a 
pharmacy setting in Glasgow, Scotland (27) and primary care based programmes in 
Nottingham and North Cumbria, England, both of which offered one to one behavioural 
support with some group support (28-29).  All clients were also offered pharmacotherapy 
during their quit attempt. This medication was free except for a small prescription charge 
paid by some clients. All programmes were delivered by trained advisors based on 
national guidelines. However these guidelines allowed services to offer their programmes 
in venues and formats that suited the local population; thus there were variations in 
programme content within as well as between sites.  Further information on the nature and 
content of services and the areas in which they were offered is available elsewhere (27-29) 
Clients who attended the Glasgow services between March and May 2007 and the English 
services between October 2001 and March 2003 were included.   
 
The outcome variable was CO validated continuous abstinence at 52 weeks.  Data 
collection complied with the Russell standard commonly used in smoking cessation 
studies (27-30).  
 
To measure SEP, five indicators of socioeconomic status (housing tenure, paying for 
prescriptions, employment status, neighbourhood deprivation and household type) were 
divided into two categories: one of which was more affluent than the other.  These were 
home owner (not renter or other), pays for prescriptions not free, other employment status 
than unemployed, permanently sick or disabled, not in the most deprived quintile of 
neighbourhoods (as measured by the indices of multiple deprivation for England and 
Scotland) and other household type rather than single parent.  This formed a scale of 
affluent indicators.  Clients’ positions ranged between 0 and 5 indicators of affluence.   
 
Demographic measures included age quartiles (the boundaries were 34, 42 and 50), 
gender, ethnicity (White British, Asian, Black and Other) and location (Glasgow, 
Nottingham and North Cumbria).  Social support was measured by whether the smoker 
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had anyone (spouse/partner, family, friend or colleague) to support their quit attempt (yes 
or no) and presence of other smokers in the household (yes or no). Motivation was 
measured through determination to quit, (not at all/quite/very compared with extremely) 
and addiction was measured through time to first cigarette on waking (within the first five 
minutes or longer). Compliance was measured through attendance: number of contacts 
with services (0 to 3, 4 to 6 and 7 to 15) and number of weeks of pharmacotherapy (no 
pharmacotherapy used, non compliant (1 to 3 weeks of all of NRT, Zyban and Champix if 
used), no evidence of compliance (1 to 3 weeks of all available variables), short term 
compliance (4 to 6 weeks was the longest time that any of NRT, Zyban or Champix were 
used) and long term compliance (7 or more weeks of NRT, Zyban or Champix).  
Programme features included referral source (self compared with professional) and format 
(group or one to one).   
 
Many of the socioeconomic status measures did not apply to older people and younger 
people may have a different relationship with some of the postulated mechanisms such as 
addiction and motivation due to not being established smokers.  Thus clients under the age 
of 25 and 60 or over were excluded. 
 
Continuous abstinence rates were determined across all sites, English sites only 
(Nottingham and North Cumbria), and Glasgow one to one pharmacy based and Glasgow 
group interventions separately.  There were too few English clients who attended groups 
(n=47 (2.0%)) to analyse these separately.  Significance was determined, where sample 
size allowed, using chi square tests of linear association. 
 
The difference in the chances of quitting between low and high SEP was assessed using 
logistic regression. Clients with 0 or 1 affluent indicators were compared with clients with 
all 5 affluent indicators. Demographic factors and smoking-related variables were entered 
into the model to see if the relationship remained.   
 
Originally it was intended to look for relationships with inequalities in quitting merging 
both datasets.  Due to differences in quit rates the datasets were analysed individually.  For 
the Glasgow one to one service analysis not all variables could be entered in the same 
form because the lower quit rate increased multicollinearity.  Ethnicity was excluded due 
to small numbers. Compliance with services and pharmacology were combined as service 
users tended to stop both simultaneously.  Compliance was measured as attended all 
sessions or completed course of pharmacotherapy compared with completed neither.  
Addiction was measured as smokes cigarette within one hour of waking or longer.  
Categories of other variables had to be merged.  SEP was grouped into 0-1 affluent 
indicators, 2 to 4 affluent indicators and all affluent indicators.  Age was divided into 
tertiles (boundaries were 37 and 47 years) rather than into quartiles.. 
 
Where there was a significant relationship between SEP and quitting the extent to which 
demographic factors, and smoking factors (support, motivation, addiction, compliance and 
smoking cessation programme features) accounted for the relationship was assessed.  Any 
change in the odds ratio of SEP was recorded when these factors were removed from a full 
model.  Variables that reduced the odds ratio by 0.2 or more and changed both the 
confidence interval boundaries by 0.1 or more (to ensure that changes were not due to 
rounding or noise) were deemed to have had an effect on the relationship between SEP 
and quitting.  Finally, if variables were found to mask the relationship between SEP and 
quitting their relationship with SEP was explored. 
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RESULTS 
 
CO validated quit rates at one year (Table 1) were higher among more affluent 
respondents for both English sites and the one to one but not the group intervention 
provided in Glasgow.  However, during the study period relatively few smokers from 
disadvantaged backgrounds attended the group service.   Continuous abstinence rates at 
one year were higher in England (average 14%) than Glasgow (average 3%).  In England 
those with 4 or 5 affluent indicators had rather higher quit rates than the other groups.  In 
the Glasgow one to one service the quit rate was fairly stable except for the most affluent 
group whose quit rate was double that of the next highest category suggesting that the 
service was disproportionately benefitting the most affluent.  
 
Logistic regression (Table 2) on data from the two English sites (North Cumbria and 
Nottingham) suggested that in a bivariate model the most affluent group were 2.5 times 
more likely to quit.  This was little changed when demographic variables were added and 
2.3 when smoking related variables were included.  Thus our explanatory variables were 
able to account for a part  of the relationship between SEP and quitting.  The one to one 
format service in Glasgow was more strongly patterned by SEP than the English data 
with the most affluent being nine times more likely to quit  
 
As background the variables which predicted quitting are presented (Table 3).  Quitters 
who participated in the English services were more likely to be affluent, male, black, 
extremely motivated, attend more sessions and take pharmacotherapy for more weeks or 
did not take it at all.  Quitters from the Glasgow one to one service were more likely to be 
affluent, older, to complete the course either of pharmacotherapy or sessions and be 
referred by a professional rather than self referred.   
 
To explore what was accounting for the relationship between SEP and quitting each 
variable was removed and replaced in turn and the effect on SEP was recorded (table 4).  
The relationship between SEP and quitting was influenced (by a variable’s removal being 
associated with an increase in the odds ratio of SEP by 0.2 or more and a change in both 
the confidence interval boundaries by 0.1 or more) for the English sites, by whether clients 
complied with pharmacotherapy. For the Glasgow one to one service living without other 
smokers, not smoking within an hour of waking and professional rather than self referral 
also explained why more affluent smokers were more likely to quit. 
 
Compliance with attendance increased the odds ratio of SEP for the most disadvantaged 
smokers, because when compared to those attending for 0 to 2 sessions smokers were 
most likely to quit if they attended 4 to 6 sessions (OR 5.2 (1.1 to 24.0)).  Attending 
further sessions appeared to be almost counterproductive (OR 1.8 (0.2 to 13.6)).  
 
In summary three smoking cessation services were studied: the English cessation service 
at two sites (Nottingham and North Cumbria) and in Glasgow a pharmacy based one to 
one service and a group service.  SEP predicted quitting for the Glasgow one to one 
service and the English data.  Disadvantaged clients were less likely to quit because they 
were not complying with treatment.  In Glasgow SEP influenced quitting through age, 
social support (smokers in the household), addiction and referral route.  In England for 
disadvantaged smokers there was a curvilinear relationship between attending sessions and 
quitting.   
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DISCUSSION 
 
Main findings of the study 
The results from this study suggest a complex relationship between SEP and quitting. The 
evidence from the one to one services in Glasgow and in England (where 98% of clients 
received one to one support) confirms that disadvantage is a barrier to quitting even after 
taking part in a smoking cessation programme.   
 
The gap between the most and least advantaged at the English sites did not appear to be 
strongly affected by traditional explanations of motivation, addiction, or social support.  
Engagement in a smoking cessation programme may have overcome these issues or these 
factors may not have provided an influential contribution to inequalities in quit rates.  
Adherence to treatment, in contrast, was an important determinant of quitting and 
inequalities in quitting.  There was a tendency amongst disadvantaged smokers to attend 
fewer sessions and take medication for fewer weeks than more advantaged smokers.  Both 
were associated with lower quit rates.   
 
An approach that encourages provider and patient to be treated are equals and allows for 
reasons for non-adherence (involving for example everyday life, lay knowledge or 
deficiencies in the proposed treatment) to be seen as reasonable and rational could 
improve adherence (22-23).  It may be that services need to take a different approach with 
more disadvantaged groups to increase adherence. The life experiences of low SES groups 
may differ significantly from those of health care providers and that this may be one 
barrier to adherence (22-23).  
 
Over recent years the stigma associated with smoking may have increased as smoking 
prevalence has fallen in countries such as the UK. Feelings of stigmatisation have been 
implicated in non adherence to treatment. Currently, however, it is unclear whether low 
SEP or high SEP groups feel more or less stigmatised by their smoking (31-32). The 
impact of stigmatisation on the relationship between adherence, quitting and SEP requires 
further investigation. 
 
Very few clients from the Glasgow one to one service delivered in a pharmacy setting had 
quit at 52 weeks.  Those that did remain abstinent tended to be the most affluent.  Affluent 
smokers’ abstinence rates were enhanced by a smoke free household in addition to two 
less studied mechanisms: long term adherence to treatment, and referral source.   It has 
been suggested that self referral should increase quitting as an indicator of motivation (33) 
but here professional referral was associated with quitting.  Professional referral can in 
some cases be an indicator of smoking induced poor health which can also motivate 
quitting (34). 
 
Previously it has been suggested that inequalities in quit rates between the most and least 
disadvantaged are a reflection of different levels of addiction.  Addiction was not a major 
driver here although Glasgow one to one clients were more likely to quit if they did not 
smoke within an hour of waking.  More common measures of addiction could not be 
entered into the model due to multicollinearity but in bivariate analysis (not shown) they 
showed little relationship with quitting.  This may be a consequence of the extensive use 
of pharmacotherapy mitigating the effects of addiction. 
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Social support for the quit attempt did not predict quitting or inequalities in quitting. The 
question on social support included in our data may have been too narrow a measure.  In 
other studies disadvantaged smokers have been found to have lower overall social 
integration (12, 35) and in particular participation in formal and informal activities (36).  
Motivation to quit predicted quitting in the English dataset but did not appear to be part of 
the pathway between SEP and quitting.  Other  studies have suggested an ambiguous 
relationship between SEP and quitting and motivation (37).   
 
In this study clients who used the Nottingham service and were identified as black or 
included black in their self-reporting of ethnicity were more likely to quit despite lower 
socioeconomic position.  This is likely to be a small number anomaly.  A similar pattern 
has nevertheless been found in the North East of England (38) but numbers were too small 
to assess significance. 
 
The relationship between SEP and quitting was not completely accounted for by the 
independent variables in this study, particularly for the English sites.  Other potential 
explanations of poorer smoking cessation rates among disadvantaged smokers, which 
were not able to be explored in this dataset, include poorer mental health (39), the work 
environment such as higher levels of boredom and stress (40) and a more stressful living 
environment and stigma associated with smoking (30, 31). Disadvantaged smokers may be 
more likely to view smoking as a way of dealing with other pressures (12, 41-42) and may 
have less understanding of or concern about the health risks of smoking (12).  It is also 
possible that elements of the intervention not examined in our studies (such as the content 
or qualities of the people delivering treatment) could have influenced differences in quit 
rates.  
 
 
What is already known 
It is well established that disadvantaged smokers are less likely to stop smoking even 
when they access smoking cessation programmes.   
 
What this paper adds 
Our findings suggests that treatment compliance (especially with pharmacotherapy) and in 
some circumstances, living with other smokers and self-referral are more responsible for 
lower quit rates among disadvantaged smokers than less motivation or less social support.  
In order to reduce inequalities, smoking cessation programmes need to try and address 
these issues to increase their success with disadvantaged groups. 
 
Limitations 
This study faced a number of limitations.  About 3.5% of clients self reported that they 
had quit but did not have their smoking status validated by a CO monitor. They were 
classified as not quit for the analysis in accordance with the Russell standard (30) but it is 
likely that some of these smokers had quit, so our cessation rates are likely to be an 
underestimate.   
 
Although the data come from three contrasting areas of the UK, these areas are not 
necessarily representative of the UK population and may have idiosyncratic features.  
There was also a time lag between data collection in England and Scotland that may have 
influenced our results, particularly as relevant policy changes (such as smoke free 
legislation in Scotland) took place between the two data collection periods. Although we 
found that Scottish group service clients with low SEP had a good quit rate, there were 
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relatively few of them.  In future we would like to explore further whether group 
programmes can overcome the barrier of low SES in a larger dataset. 
 
It has been argued that the determinants of health and health behaviours are different from 
the determinants of health inequalities (43).  The same range of determinants was used for 
both in our study (tables 3 and 4).  However, as non significant predictors of quitting were 
not excluded from the analysis of variables predicting inequalities, we allowed for the 
possibility that there may be different determinants of inequalities and we found this to be 
the case. 
 
The conclusions of our analyses are also limited due to the ambiguous direction of 
causation between compliance and quitting.  Lack of compliance could have caused 
relapse or a relapse for other reasons could have prevented compliance.  In future, perhaps 
qualitative, work this direction of causation needs to be teased out.  As it stands our data 
suggests that encouraging disadvantaged smokers to comply with pharmacotherapy is 
central to equalising their chances of quitting to other smokers.  Future studies should be 
encouraged to collect data on compliance with pharmacotherapy in addition to whether or 
not pharmacotherapy was used in order to further explore the role of pharmacotherapy in 
attenuating the relationship between SEP and cessation (6). 
 
Less than 10% of quit attempts in the UK involve the use of cessation services (44).  Thus 
evidence in this paper only applies to a small proportion of smokers.  Nevertheless, these 
services are one of the most cost-effective of all healthcare interventions (45) and 
evidence of the kind outlined in this paper can contribute to expanding the reach and 
effectiveness of these programmes.   
 
In conclusion, our findings suggest that smoking cessation services face particular 
challenges in supporting more disadvantaged smokers to quit, particularly when support is 
delivered in a one to one format.  In order to mitigate the effects of disadvantage, those 
planning and delivering services should take into account that these smokers may have 
other smokers in their home environment, pay particular attention to those who self refer 
and  support and encourage these clients to take pharmacotherapy correctly and attend 
sessions for long enough to improve their chances of successfully quitting. 
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Table 1 Quit rates by socioeconomic position 
 All sites England only Glasgow only 
Glasgow 
one-to-one 
Glasgow 
group 
  
N  2397 1377 996 695 301 
      
   N (% quit)   
SEP      
0-1 affluent indicator 507   (5.1%) 230   (8.7%) 277 (2.2%) 227 (0.9%) 50 (8.0%) 
2 affluent indicators 395   (9.1%) 240 (12.5%) 155 (3.9%) 116 (3.4%) 39 (5.1%) 
3 affluent indicators 485   (6.4%) 294   (9.2%) 191 (2.1%) 135 (2.2%) 56 (1.8%) 
4 affluent indicators 703 (13.4%) 463 (18.8%) 240 (2.9%) 149 (2.0%) 91 (4.4%) 
5 affluent indicators 307 (14.3%) 174 (19.5%) 133 (7.5%) 68 (7.4%) 65 (7.7%) 
      
total 9.6% 14.1% 3.3% 2.4% 5.3% 
P (linear association) <.001 <.001 NA NA NA 
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Table 2 Odds ratios (95% confidence intervals) of quitting by socioeconomic position 
 England only 
Glasgow 
one-to-one 
N 1305 687 
   
SEP* only    
0-1 affluent indicator 1 1 
5 affluent indicators 2.5 (1.3 to 4.6) 9.1 (1.7 to 48.3) 
   
(+demographic )   
0-1 affluent indicator 1 1 
5 affluent indicators 2.5 (1.4 to 4.7) 7.5 (1.4 to 40.3) 
   
(+ cessation related)   
0-1 affluent indicator 1 1 
5 affluent indicators 2.3 (1.2 to 4.4) 5.1 (0.8 to 31.2) 
   
* SEP was entered as 5 categories England and 3 categories (0-1, 2-4 & all)  Glasgow one to one 
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Table 3 Full models showing OR (95%CI)  for eachcandidate predictor of CO validated quitting 
 England Glasgow one to one  
 N OR (95%CI)  N OR (95%CI) 
SEP   SEP   
0-1 affluent indicator 220 1 0-1 affluent indicators 225 1 
2 affluent indicators 224 1.6 (0.8 to 3.0) 2-4 affluent indicators 396 2.0 (0.4 to 9.8) 
3 affluent indicators 267 1.1 (0.6 to 2.2) All affluent indicators 66 5.1 (0.8 to 31.2) 
4 affluent indicators 434 2.3 (1.3 to 4.1)    
All affluent indicators 160 2.3 (1.2 to 4.4)    
Age  quartiles   Age  tertiles   
25-34 352 1 25-37 260 1 
35-42 350 1.2 (0.8 to 2.0) 38-47 243 2.6 (0.4 to 15.2) 
43-50 277 1.4 (0.8 to 2.3) 48-59 184 5.8 (1.1 to 30.2) 
51-59 326 1.5 (0.9 to 2.4)    
Gender   Gender   
female 748 1 female 387 1 
male 557 1.5 (1.1 to 2.1) male 300 0.9 (0.3 to 2.8) 
Ethnicity      
White British 1238 1    
Asian mentioned 17 0.6 (0.1 to 4.9)    
Black mentioned 15 6.9 (2.1 to 23.2)    
other/unknown 35 0.2 (0.0 to 1.5)    
Location      
Glasgow      
Nottingham 565 1    
North Cumbria 740 1.3 (0.9 to 2.0)    
Support to quit   Support to quit   
no support 93 1 no support 165 1 
support 1212 1.6 (0.8 to 3.4) support 522 1.0 (0.3 to 3.8) 
Household smokers   Household smokers   
other smoker(s) 547 1 other smoker(s) 303 1 
only smoker 758 1.3 (0.9 to 1.8) only smoker 384 3.0 (0.8 to 11.2) 
Determination to quit   Determination to quit   
not at all/quite/very 793 1 not at all/quite/very 437 1 
extremely 512 1.5 (1.1 to 2.1) extremely 250 2.4 (0.8 to 7.5) 
Time to first daily smoke   Time to first daily smoke   
within 5 mins 472 1 within 1 hour 640 1 
longer 833 1.2 (0.8 to 1.8) longer 47 3.4 (0.7 to 15.9) 
Attendance     Compliance   
0 to 3 contacts 455 1 Did not finish either 592 1 
4 to 6 contacts 624 2.0 (1.3 to 3.2) Finished NRT or sessions 95 9.5 (3.0 to 30.2) 
7 to 15 contacts 177 2.6 (1.4 to 4.7)    
contacts unknown 49 1.6 (0.6 to 4.6)    
Pharmacotherapy      
no pharmacotherapy  25 4.9 (1.5 to 15.5)    
non compliant (<4 weeks) 253 1    
no evidence of compliance  273 2.3 (1.0 to 4.9)    
compliant (4-6 weeks) 447 3.0 (1.4 to 6.1)    
compliant (7+ weeks) 307 4.8 (2.3 to 10.3)    
Referral   Referral   
Self referred 706 1 Self referred 525 1 
Professional referred 599 1.1 (0.7 to 1.5) Professional referred 162 4.0 (1.3 to 11.9) 
Intervention format      
individual 1262 1    
group 43 1.2 (0.5 to 3.2)    
 17 
 
Table 4 The effect on the odds ratio of SEP* of removing other variables singly   
 England 
Glasgow  
one-to-one  
SEP only 2.5 (1.3 to 4.6) 9.1 (1.7 to 48.3) 
Demographic related 2.5 (1.4 to 4.7) 7.5 (1.4 to 40.3) 
Cessation related 2.3 (1.2 to 4.4) 5.1 (0.8 to 31.2) 
   
 Variable removed   
- Age 2.3 (1.2 to 4.5) 5.4 (0.9 to 32.2) 
- Gender 2.4 (1.2 to 4.6) 5.1 (0.8 to 31.0) 
- Ethnicity 2.2 (1.1 to 4.2)  
- Location 2.3 (1.2 to 4.4)  
-Support 2.3 (1.2 to 4.5) 5.1 (0.8 to 31.1) 
- Household smoker 2.2 (1.2 to 4.3) 5.9 (1.0 to 35.0) 
- Determination to quit 2.3 (1.2 to 4.4) 4.8 (0.8 to 28.3) 
- Time to first cigarette 2.4 (1.3 to 4.6) 5.8 (0.9 to 35.2) 
- Compliance  6.5 (1.1 to 37.9) 
 - compliance attendance 2.0 (1.0 to 3.8)  
 - compliance pharmacotherapy 2.5 (1.3 to 4.8)  
- Referral 2.3 (1.2 to 4.4) 6.4 (1.1 to 38.1) 
- Intervention format 2.3 (1.2 to 4.4)  
   
* SEP was entered as 5 categories England and 3 categories (0-1, 2-4 & all)  Glasgow one to one 
 
 
